Genomics
We provide solutions to our clients from Pre-Clinical & Discovery through to Clinical Trial & CDx Support. Frontage uses advanced technologies and state-of-the-art equipment to provide fast, accurate, and customized results you can trust.
Learn More
Frontage offers a comprehensive portfolio of genomics services to meet the needs of our clients
Frontage offers end-to-end genomics services, from nucleic acid isolation through data analysis and interpretation, to provide manageable datasets and comprehensive results packages.

Oncology
Sensitive and reliable assays for the detection of variants in cancer-related genes from a variety of sample types.

Pharmacogenetics
The genomics team at Frontage has expertise in variant detection and genotyping a variety of methods.

Metagenomics & Microbiome
Solving development problems of probiotics and prebiotics
Rapid Turn-Around Times
At Frontage, we pride ourselves on the ability to offer rapid turn-around times for all genomics services. Our workflows are optimized for high-throughput samples processing to accommodate a large number of samples in a short amount of time.
Meeting Regulatory Standards
Our genomics services laboratory is CLIA-certified and CAP-accredited and meets the GLP regulatory standards.
Frontage offers pre-validated NGS-based LTDs for oncology and pharmacogenomics that are CAP-accredited. Custom NGS, qPCR, or droplet digital PCR assays can be set up and validated under GLP or CLIA.
Navigate the Landscape
of Biomarker Discovery
Check out our eBook entitled Sequencing Assays for Biomarker Discovery and Pharmacodynamics in Oncology Studies.
Download eBook HereResources To Consider


Exome sequencing shows same pattern of clonal tumor mutational…

WRIB 2024: High-quality RNA-seq Library Preparation from…

AAPS 2024: A GxP-Qualified dPCR-Based RCL Assay to Quantify…

Clonal Neoantigen: Emerging “Mechanism-based” Biomarker of…

RNA-Seq Workflow Optimization for Heavily Degraded FFPE Samples with…

WRIB 2022: Optimization and standardization of RNA-seq operation to…

AACR 2023: Evaluation of a 293 gene oncology-focused exome sequencing…

AACR 2024: Analytical validation of a complete system for detection…

Genomics: A Customized NGS Sequencing

Validation of a 384 gene hybridization capture-based pharmacogenomics…

Cell-Free DNA NGS Testing
